Joel Greenblatt's GMED Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 94,544 shares of Globus Medical, Inc. (GMED) worth $8.25 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in GMED, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 812,760 shares. Largest reduction occurred in Q4 2014, reducing 594,100 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -14,785 | Reduce 13.52% | 94,544 | $87.31 |
| Q3 2025 | -134,747 | Reduce 55.21% | 109,329 | $57.27 |
| Q2 2025 | +116,303 | Add 91.02% | 244,076 | $59.02 |
| Q1 2025 | +93,606 | Add 273.97% | 127,773 | $73.20 |
| Q4 2024 | +34,167 | New Buy | 34,167 | $82.71 |
| Q4 2023 | -12,145 | Sold Out | 0 | $0.00 |
| Q3 2023 | +4,388 | Add 56.57% | 12,145 | $49.65 |
| Q2 2023 | +7,757 | New Buy | 7,757 | $59.54 |
| Q3 2022 | -13,039 | Sold Out | 0 | $0.00 |
| Q2 2022 | +5,516 | Add 73.32% | 13,039 | $56.14 |
| Q1 2022 | -15,127 | Reduce 66.79% | 7,523 | $73.77 |
| Q4 2021 | +14,348 | Add 172.83% | 22,650 | $72.19 |
| Q3 2021 | +1,932 | Add 30.33% | 8,302 | $76.61 |
| Q2 2021 | +2,260 | Add 54.99% | 6,370 | $77.55 |
| Q1 2021 | -2,415 | Reduce 37.01% | 4,110 | $61.56 |
| Q4 2020 | -16,828 | Reduce 72.06% | 6,525 | $65.29 |
| Q3 2020 | -657 | Reduce 2.74% | 23,353 | $49.50 |
| Q2 2020 | +7,713 | Add 47.33% | 24,010 | $47.73 |
| Q1 2020 | +16,297 | New Buy | 16,297 | $42.52 |
| Q4 2019 | -14,177 | Sold Out | 0 | $0.00 |
| Q3 2019 | -7,345 | Reduce 34.13% | 14,177 | $51.14 |
| Q2 2019 | -74,370 | Reduce 77.56% | 21,522 | $42.28 |
| Q1 2019 | +661 | Add 0.69% | 95,892 | $49.41 |
| Q4 2018 | -87,404 | Reduce 47.86% | 95,231 | $43.28 |
| Q3 2018 | -104,201 | Reduce 36.33% | 182,635 | $56.76 |
| Q2 2018 | -3,276 | Reduce 1.13% | 286,836 | $50.46 |
| Q1 2018 | -12,391 | Reduce 4.10% | 290,112 | $49.82 |
| Q4 2017 | -48,124 | Reduce 13.73% | 302,503 | $41.10 |
| Q3 2017 | +274,906 | Add 363.05% | 350,627 | $29.72 |
| Q2 2017 | +15,200 | Add 25.12% | 75,721 | $33.15 |
| Q1 2017 | -96,762 | Reduce 61.52% | 60,521 | $29.63 |
| Q4 2016 | -574,895 | Reduce 78.52% | 157,283 | $24.81 |
| Q3 2016 | +111,077 | Add 17.88% | 732,178 | $22.57 |
| Q2 2016 | +402,116 | Add 183.63% | 621,101 | $23.83 |
| Q1 2016 | +218,985 | New Buy | 218,985 | $23.75 |
| Q4 2015 | -159,743 | Sold Out | 0 | $0.00 |
| Q3 2015 | -25,471 | Reduce 13.75% | 159,743 | $20.66 |
| Q2 2015 | -60,188 | Reduce 24.53% | 185,214 | $25.67 |
| Q1 2015 | -326,365 | Reduce 57.08% | 245,402 | $25.24 |
| Q4 2014 | -594,100 | Reduce 50.96% | 571,767 | $23.77 |
| Q3 2014 | +245,587 | Add 26.69% | 1.17 M | $19.67 |
| Q2 2014 | +812,760 | Add 755.92% | 920,280 | $23.92 |
| Q1 2014 | -19,569 | Reduce 15.40% | 107,520 | $26.59 |
| Q4 2013 | +127,089 | New Buy | 127,089 | $20.18 |
| Q3 2013 | -10,113 | Sold Out | 0 | $0.00 |
| Q2 2013 | +10,113 | Add 0.00% | 10,113 | $16.91 |
Joel Greenblatt's Globus Medical Investment FAQs
Joel Greenblatt first purchased Globus Medical, Inc. (GMED) in Q2 2013, acquiring 10,113 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Globus Medical, Inc. (GMED) for 46 quarters since Q2 2013.
Joel Greenblatt's largest addition to Globus Medical, Inc. (GMED) was in Q2 2014, adding 920,280 shares worth $22.01 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 94,544 shares of Globus Medical, Inc. (GMED), valued at approximately $8.25 M.
As of the Q4 2025 filing, Globus Medical, Inc. (GMED) represents approximately 0.03% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Globus Medical, Inc. (GMED) was 1,165,867 shares, as reported at the end of Q3 2014.